A call to action to implement prescribing authority to pharmacists for hypertension management.
作者信息
Khan Nadia, Bell Alan, Berg Angelique, Campbell Norm, Kaczorowski Janusz, Rabi Doreen, Schiffrin Ernesto L, Tsuyuki Ross T
出版信息
Can Pharm J (Ott). 2019 Jul 22;152(5):285-287. doi: 10.1177/1715163519866144. eCollection 2019 Sep-Oct.
Abstract
摘要
相似文献
1
A call to action to implement prescribing authority to pharmacists for hypertension management.
Can Pharm J (Ott). 2019 Jul 22;152(5):285-287. doi: 10.1177/1715163519866144. eCollection 2019 Sep-Oct.
2
Health Authority Pharmacists' Perceptions of Independent Pharmacist Prescribing.
Can J Hosp Pharm. 2019 May-Jun;72(3):185-193. Epub 2018 Jun 30.
3
Perceptions of Independent Pharmacist Prescribing among Health Authority- and Community-Based Pharmacists in Northern British Columbia.
Pharmacy (Basel). 2021 Apr 23;9(2):92. doi: 10.3390/pharmacy9020092.
4
Prescribing authority: an examination of Ohio pharmacists' opinions.
Am Pharm. 1995 Oct;NS35(10):19-23. doi: 10.1016/s0160-3450(15)30046-5.
5
The road to pharmacist prescribing in Alberta Health Services.
Am J Health Syst Pharm. 2016 Sep 15;73(18):1451-5. doi: 10.2146/ajhp150786.
6
Advancing pharmacist prescribing privileges: Is it time?
J Am Pharm Assoc (2003). 2019 Nov-Dec;59(6):783-786. doi: 10.1016/j.japh.2019.08.004. Epub 2019 Sep 12.
7
Stakeholders' views on granting prescribing authority to pharmacists in Nigeria: a qualitative study.
Int J Clin Pharm. 2016 Aug;38(4):960-7. doi: 10.1007/s11096-016-0321-6. Epub 2016 May 18.
8
Toward a rational approach to the issue of prescribing authority for pharmacists.
Drug Intell Clin Pharm. 1983 Sep;17(9):660-6. doi: 10.1177/106002808301700919.
9
Initial perceptions of key stakeholders in Ontario regarding independent prescriptive authority for pharmacists.
Res Social Adm Pharm. 2014 Mar-Apr;10(2):341-54. doi: 10.1016/j.sapharm.2013.05.008. Epub 2013 Jun 28.
10
Revisiting the continuum of pharmacist prescriptive authority.
J Am Pharm Assoc (2003). 2023 Sep-Oct;63(5):1508-1514. doi: 10.1016/j.japh.2023.06.025. Epub 2023 Jul 5.
引用本文的文献
1
A hyper-opportunity for pharmacy.
Can Pharm J (Ott). 2025 May 29:17151635251342414. doi: 10.1177/17151635251342414.
2
Hypertension Canada's 2020 hypertension guidelines for pharmacists: An update.
Can Pharm J (Ott). 2020 Dec 10;154(1):19-25. doi: 10.1177/1715163520975809. eCollection 2021 Jan-Feb.
3
Development and implementation of blood pressure screening and referral guidelines for German community pharmacists.
J Clin Hypertens (Greenwich). 2020 Oct;22(10):1807-1816. doi: 10.1111/jch.14020. Epub 2020 Aug 30.
4
Pharmacists can improve hypertension care (but you have to pay them . . .): A review of remuneration opportunities across Canada.
Can Pharm J (Ott). 2020 Jan 15;153(1):7-8. doi: 10.1177/1715163519892207. eCollection 2020 Jan-Feb.
本文引用的文献
1
Cost-effectiveness of pharmacist care for managing hypertension in Canada.
Can Pharm J (Ott). 2017 Mar 21;150(3):184-197. doi: 10.1177/1715163517701109. eCollection 2017 May-Jun.
2
Perceptions of interprofessional collaboration of general practitioners and community pharmacists - a qualitative study.
BMC Health Serv Res. 2017 Mar 21;17(1):224. doi: 10.1186/s12913-017-2157-8.
3
Effectiveness of a Pharmacist-Physician Team-Based Collaboration to Improve Long-Term Blood Pressure Control at an Inner-City Safety-Net Clinic.
Pharmacotherapy. 2016 Mar;36(3):342-7. doi: 10.1002/phar.1710. Epub 2016 Feb 24.
4
Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
Pharmacotherapy. 2016 Apr;36(4):374-84. doi: 10.1002/phar.1727. Epub 2016 Mar 18.
5
Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION).
Circulation. 2015 Jul 14;132(2):93-100. doi: 10.1161/CIRCULATIONAHA.115.015464. Epub 2015 Jun 10.
6
Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control.
Circ Cardiovasc Qual Outcomes. 2015 May;8(3):235-43. doi: 10.1161/CIRCOUTCOMES.114.001283. Epub 2015 Mar 24.
7
Effects of nurse-managed protocols in the outpatient management of adults with chronic conditions: a systematic review and meta-analysis.
Ann Intern Med. 2014 Jul 15;161(2):113-21. doi: 10.7326/M13-2567.
8
Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials.
J Am Heart Assoc. 2014 Apr 10;3(2):e000718. doi: 10.1161/JAHA.113.000718.
9
Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies.
PLoS One. 2014 Jan 15;9(1):e84238. doi: 10.1371/journal.pone.0084238. eCollection 2014.
10
The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries.
Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD010398. doi: 10.1002/14651858.CD010398.
Zotero 插件